CY1118780T1 - Μεθοδοι και συνθεσεις για χορηγηση σιδηρου - Google Patents
Μεθοδοι και συνθεσεις για χορηγηση σιδηρουInfo
- Publication number
- CY1118780T1 CY1118780T1 CY20161101047T CY161101047T CY1118780T1 CY 1118780 T1 CY1118780 T1 CY 1118780T1 CY 20161101047 T CY20161101047 T CY 20161101047T CY 161101047 T CY161101047 T CY 161101047T CY 1118780 T1 CY1118780 T1 CY 1118780T1
- Authority
- CY
- Cyprus
- Prior art keywords
- iron
- carbohydrate
- compositions
- methods
- single unit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα εφεύρεση γενικώς αφορά σε θεραπεία σχετικών με σίδηρο καταστάσεων με σύμπλοκα σιδήρου υδατάνθρακα. Μία άποψη της εφεύρεσης είναι μία μέθοδος θεραπείας σχετικών με σίδηρο καταστάσεων με απλής μονάδας δοσολογία από τουλάχιστον περίπου 0,6 γραμμάρια στοιχειακού σιδήρου μέσω συμπλόκου σιδήρου υδατάνθρακα. Η μέθοδος γενικώς χρησιμοποιεί σύμπλοκα σιδήρου υδατάνθρακα με σχεδόν ουδέτερο pΗ, φυσιολογική οσμωτικότητα, και σταθερά και μη ανοσογονικά συστατικά υδατάνθρακα έτσι ώστε να χορηγούνται ταχέως υψηλές απλής μονάδας δόσεις σιδήρου ενδοφλεβίως σε ασθενείς που έχουν ανάγκη αυτών.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75711906P | 2006-01-06 | 2006-01-06 | |
PCT/US2007/000176 WO2007081744A2 (en) | 2006-01-06 | 2007-01-08 | Methods and compositions for administration of iron |
US11/620,986 US7754702B2 (en) | 2006-01-06 | 2007-01-08 | Methods and compositions for administration of iron |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118780T1 true CY1118780T1 (el) | 2017-07-12 |
Family
ID=38233459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161101047T CY1118780T1 (el) | 2006-01-06 | 2016-10-19 | Μεθοδοι και συνθεσεις για χορηγηση σιδηρου |
Country Status (11)
Country | Link |
---|---|
US (11) | US7754702B2 (el) |
EP (3) | EP1973549B1 (el) |
KR (4) | KR20140117678A (el) |
CN (1) | CN101365458B (el) |
AU (1) | AU2007205167B2 (el) |
CA (2) | CA2635894C (el) |
CY (1) | CY1118780T1 (el) |
DK (1) | DK1973549T3 (el) |
HK (1) | HK1125044A1 (el) |
PT (1) | PT1973549T (el) |
WO (1) | WO2007081744A2 (el) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
US20060116349A1 (en) * | 2003-03-14 | 2006-06-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
EP1790356A1 (de) * | 2005-11-24 | 2007-05-30 | Vifor (International) Ag | Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en) |
DK1973549T3 (en) | 2006-01-06 | 2016-11-21 | Vifor (International) Ag | Methods and compositions for administration of the iron |
AU2008353469B2 (en) * | 2008-03-28 | 2014-12-11 | Chyna Llc | Use of ferritin to treat iron deficiency disorders |
GB0808835D0 (en) * | 2008-05-15 | 2008-06-18 | Vitra Pharmaceuticals Ltd | Therapeutic compositions |
EP2296998A1 (en) * | 2008-05-23 | 2011-03-23 | Hospira, Inc. | Packaged iron sucrose products |
CN105902482A (zh) * | 2008-06-25 | 2016-08-31 | Fe3医学有限公司 | 用于经皮递送治疗有效量的铁的贴片和方法 |
KR101017432B1 (ko) * | 2008-11-06 | 2011-02-28 | (주)유케이케미팜 | 함당산화철 제조방법 |
HUE030866T2 (en) | 2009-03-25 | 2017-06-28 | Pharmacosmos Holding As | Stable iron-oligosaccharide compound |
US8058076B2 (en) * | 2009-03-31 | 2011-11-15 | Astron Research Limited | In-vitro method for testing bioequivalence of iron-sucrose formulation |
US8821945B2 (en) | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
MX2012000892A (es) | 2009-07-21 | 2012-06-01 | Keryx Biopharmaceuticals Inc | Formas de dosificacion de citrato ferrico. |
IT1405688B1 (it) * | 2010-06-09 | 2014-01-24 | Biofer Spa | Nuovi complessi a basso peso molecolare tra ferro ed acido maltobionico, uso di questi per la somministrazione intramuscolare o sottocutanea nella terapia di stati anemici, e nuove composizioni farmaceutiche adatte a questi usi. |
EP2420243A1 (en) | 2010-08-18 | 2012-02-22 | Inovativo Biomedicinas Tehnologiju Instituts, SIA | Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming |
CN102451185A (zh) | 2010-10-19 | 2012-05-16 | 长春纳米生技公司 | 金属离子纳米簇组合物 |
WO2012092628A2 (en) * | 2010-12-31 | 2012-07-05 | Incube Labs, Llc | Patches and methods for the transdermal delivery of agents to treat hair loss |
CN102153651B (zh) * | 2011-01-21 | 2012-11-14 | 厦门大学 | 抗葡聚糖单链抗体及其制备方法 |
ES2650918T3 (es) | 2011-12-30 | 2018-01-23 | Sloiron, Inc. | Procedimientos de aislamiento, uso y análisis de ferritina |
PL3730136T3 (pl) * | 2012-06-21 | 2024-03-25 | Keryx Biopharmaceuticals, Inc. | Zastosowanie cytrynianu żelaza(iii) w leczeniu pacjentów z przewlekłą chorobą nerek |
EP2877848A4 (en) * | 2012-07-27 | 2016-03-23 | Intrinsic Life Sciences Llc | METHOD FOR TREATING FERMENTED ANEMIA |
KR102218494B1 (ko) | 2013-03-15 | 2021-02-19 | 인트린식 라이프사이언시스, 엘엘씨 | 항-헵시딘 항체 및 그의 용도 |
US9370202B2 (en) | 2013-03-15 | 2016-06-21 | LG Bionano, LLC | Encapsulated metal ion nanoclusters |
JP6049194B2 (ja) * | 2013-03-28 | 2016-12-21 | 富士フイルム株式会社 | グラフ表示装置およびグラフ表示装置の作動方法並びにグラフ表示プログラム |
ES2856261T3 (es) | 2013-10-01 | 2021-09-27 | Fresenius Medical Care Deutschland Gmbh | Método y aparatos para determinar una pérdida diaria de hierro de un paciente |
KR101536325B1 (ko) * | 2013-10-16 | 2015-07-14 | 주식회사 지니스 | 전자기파를 이용한 암 온열치료용 감작제 조성물 및 이를 이용한 암 치료 방법 |
KR20150078375A (ko) * | 2013-12-30 | 2015-07-08 | 한화케미칼 주식회사 | 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물 |
TWI689310B (zh) | 2014-07-11 | 2020-04-01 | 巨生生醫股份有限公司 | 治療鐵缺乏症之方法 |
EP3197915A4 (en) | 2014-09-22 | 2018-12-19 | Intrinsic Lifesciences LLC | Humanized anti-hepcidin antibodies and uses thereof |
EP2913054A1 (en) * | 2015-03-19 | 2015-09-02 | Pharmacosmos Holding A/s | Iron carbohydrate complex for treatment of restless leg syndrome (rls) |
WO2016196274A1 (en) * | 2015-05-29 | 2016-12-08 | Luitpold Pharmaceuticals, Inc. | Compositions and methods for treatment of fibromyalgia |
EP3310364B1 (en) | 2015-06-22 | 2021-09-15 | Pharmacosmos Holding A/s | Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant |
CA2932075C (en) * | 2015-09-01 | 2020-11-17 | Particle Dynamics International, Llc | Iron-polysaccharide complexes and methods for the preparation thereof |
US10258647B2 (en) | 2015-09-01 | 2019-04-16 | Particle Dynamics International, Llc | Iron-polysaccharide complexes and methods for the preparation thereof |
US20180296595A1 (en) * | 2015-09-11 | 2018-10-18 | Memorial Sloan Kettering Cancer Center | Methods and compositions for cancer treatment |
CN105520955B (zh) * | 2015-12-21 | 2018-05-11 | 南京生命能科技开发有限公司 | 一种羧基麦芽糖铁药用组合物及其制备方法 |
CN105708805A (zh) * | 2016-01-28 | 2016-06-29 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁及其制备方法 |
CN105708792A (zh) * | 2016-01-28 | 2016-06-29 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁注射液及其制备方法 |
CN105616372A (zh) * | 2016-01-28 | 2016-06-01 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁片剂 |
CN105726569A (zh) * | 2016-03-02 | 2016-07-06 | 东南大学 | 聚糖超顺磁氧化铁在制备治疗心血管疾病药物方面的应用 |
WO2019152618A1 (en) * | 2018-01-31 | 2019-08-08 | University Of Maryland, Baltimore | A comprehensive method to quantify iron distribution in plasma |
BR112021008142A2 (pt) | 2018-10-29 | 2021-08-03 | Pharmacosmos Holding A/S | tratamento de deficiência de ferro com carboximaltose férrica |
US11726049B2 (en) * | 2020-05-04 | 2023-08-15 | Amphastar Pharmaceuticals, Inc. | Small angle x-ray scattering methods for characterizing the iron core of iron carbohydrate colloid drug products |
CN115364114B (zh) * | 2021-05-21 | 2023-12-01 | 武汉科福新药有限责任公司 | 羧基麦芽糖铁药用组合物及其制备方法 |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE370194C (de) | 1923-02-28 | Therese Rocksch Geb Laschet | Elektrolytisches Zinnbad zur Darstellung schwammfreier Zinnkristalle | |
CA623411A (en) | 1961-07-04 | Muller Arthur | Process for the manufacture of iron-polyisomaltose complex for therapeutical purposes | |
US1199951A (en) | 1915-11-06 | 1916-10-03 | Robert E Leigh | Lubricating device. |
CH123744A (de) | 1925-09-04 | 1927-12-16 | Anode Rubber Company Limited | Verfahren zur Herstellung von homogenen Niederschlägen aus wässerigen Dispersionen kautschukartiger Stoffe auf metallischen Niederschlagungsunterlagen. |
GB335965A (en) | 1929-06-05 | 1930-10-06 | Ig Farbenindustrie Ag | Process for the manufacture of complex iron compounds |
US2807610A (en) | 1952-02-15 | 1957-09-24 | Baker Chem Co J T | Hydrogenated dextran |
GB748024A (en) | 1953-02-27 | 1956-04-18 | Benger S Ltd | Improved therapeutic preparations of iron |
GB879441A (en) | 1959-05-25 | 1961-10-11 | Crookes Lab Ltd | Improved injectable iron preparations |
US3065138A (en) | 1959-10-09 | 1962-11-20 | Warren Teed Products Company | Therapeutic preparations of elemental iron |
US3100202A (en) * | 1960-06-17 | 1963-08-06 | Muller Arthur | Process for preparing an iron hydroxide polyisomaltose complex and the resulting product |
US3151107A (en) | 1960-12-22 | 1964-09-29 | Central Pharmacal Company | Water-soluble iron complexes of carboxymethyl dextran |
US3076798A (en) | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
GB985206A (en) | 1961-12-20 | 1965-03-03 | Hausmann Ag Labor | Improvements in or relating to therapeutic iron preparation |
ES282099A1 (es) | 1962-11-02 | 1963-01-01 | Rocador Sa | Procedimiento para la preparación de un complejo de óxido de hierro y ácidos dextránicos |
FR1451203A (fr) | 1964-01-31 | 1966-01-07 | Rocador Sa | Procédé pour la fabrication d'un complexe d'oxyde ferrique et de polysaccharide |
GB1183940A (en) | 1966-10-22 | 1970-03-11 | Fisons Pharmaceuticals Ltd | Ferric Hydroxide Complexes |
US3639588A (en) | 1966-10-22 | 1972-02-01 | Fisons Pharmaceuticals Ltd | Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids |
GB1199951A (en) | 1967-05-13 | 1970-07-22 | Fisons Pharmaceuticals Ltd | Modified Dextran and Derivatives Thereof |
GB1200902A (en) | 1967-05-13 | 1970-08-05 | Fisons Pharmaceuticals Ltd | Iron-dextran complexes |
US3395229A (en) | 1967-07-03 | 1968-07-30 | Mattox And Moore Inc | Process and product for combatting iron deficiency anemia in suckling pigs |
US3821192A (en) | 1971-08-18 | 1974-06-28 | Central Pharmacal Co | Process for preparing an iron-saccharide complex |
SE359447B (el) | 1971-10-06 | 1973-09-03 | Astra Laekemedel Ab | |
US3928581A (en) | 1972-09-13 | 1975-12-23 | Astra Laekemedel Ab | Certain polymer-iron complexes for treatment of iron deficiency |
US3965133A (en) | 1972-10-04 | 1976-06-22 | Astra Lakemedel Aktiebolag | Polymer |
US3969395A (en) | 1972-10-04 | 1976-07-13 | Astra Lakemedel Aktiebolag | Polymers of hydroxy carboxylic acid and a polyhydric alcohol |
US4056672A (en) | 1973-03-22 | 1977-11-01 | Astra Lakemedel Aktiebolag | Polymer prepared by cyanhydrin method |
JPS6039681B2 (ja) | 1976-01-01 | 1985-09-07 | 日本臓器製薬株式会社 | デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤 |
US4180567A (en) | 1977-09-02 | 1979-12-25 | Pharmachem Corporation | Iron preparations and methods of making and administering the same |
US4370476A (en) | 1979-07-17 | 1983-01-25 | Usher Thomas C | Dextran polycarboxylic acids, ferric hydroxide complexes |
DE3026868C2 (de) | 1980-07-16 | 1986-03-13 | Laboratorien Hausmann AG, St. Gallen | Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung |
US4335116A (en) | 1980-10-07 | 1982-06-15 | University Patents, Inc. | Mineral-containing therapeutic compositions |
EP0051707A1 (en) | 1980-11-12 | 1982-05-19 | Thomas Clemens Usher | Dextran polycarboxylic acids, ferric hydroxide complexes thereof, pharmaceutical compositions containing them and methods for their manufacture |
US4788281A (en) | 1984-01-04 | 1988-11-29 | Tosoni Anthony L | Dextran hexonic acid derivative, ferric hydroxide complex and method manufacture thereof |
US4689235A (en) | 1984-01-31 | 1987-08-25 | Scm Corporation | Encapsulation matrix composition and encapsulate containing same |
US4612284A (en) | 1984-09-28 | 1986-09-16 | A. E. Staley Manufacturing Company | Process for the enzymatic hydrolysis of non-gelatinized granular starch material directly to glucose |
US5160726A (en) | 1990-02-15 | 1992-11-03 | Advanced Magnetics Inc. | Filter sterilization for production of colloidal, superparamagnetic MR contrast agents |
US5102652A (en) | 1986-07-03 | 1992-04-07 | Advanced Magnetics Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
JP2858752B2 (ja) | 1987-04-10 | 1999-02-17 | オーソ・フアーマシユーチカル・コーポレーシヨン | 正常な哺乳動物のヘマトクリツト値の増大方法 |
GB8902894D0 (en) | 1989-02-09 | 1989-03-30 | Fisons Plc | Compositions |
JP2726520B2 (ja) | 1989-10-20 | 1998-03-11 | 名糖産業株式会社 | 有機磁性複合体 |
AU652060C (en) | 1991-06-11 | 2004-04-22 | Meito Sangyo Kabushiki Kaisha | Oxidized composite comprising water-soluble carboxypolysaccharide and magnetic iron oxide |
TW293036B (el) | 1992-11-27 | 1996-12-11 | Takeda Pharm Industry Co Ltd | |
EP0634174A1 (en) | 1993-07-13 | 1995-01-18 | Takeda Chemical Industries, Ltd. | Antianemic composition for veterinary use |
US5624668A (en) * | 1995-09-29 | 1997-04-29 | Luitpold Pharmaceuticals, Inc. | Iron dextran formulations |
EP0859795B1 (en) | 1995-11-09 | 2003-04-02 | Abbott Laboratories | Process for making crystalline iron dextran |
US5756715A (en) | 1996-11-08 | 1998-05-26 | Abbott Laboratories | Process for making crystalline iron dextran |
CA2195283C (en) | 1997-01-16 | 2008-07-22 | Thomas C. Usher | Process for manufacturing iron dextran using ultrafiltration |
US6219440B1 (en) | 1997-01-17 | 2001-04-17 | The University Of Connecticut | Method and apparatus for modeling cellular structure and function |
US6010719A (en) | 1997-09-16 | 2000-01-04 | Universiteit Gent | Freeze-dried disintegrating tablets |
DK172860B1 (da) | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
DE19833548A1 (de) | 1998-07-25 | 2000-02-03 | Messer Griesheim Gmbh | Überkritische Fluorierung |
US6587550B2 (en) | 1998-09-02 | 2003-07-01 | Michael O. Council | Method and apparatus for enabling a fee to be charged to a party initiating an electronic mail communication when the party is not on an authorization list associated with the party to whom the communication is directed |
DK173138B1 (da) | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma |
US7871597B2 (en) | 1999-04-09 | 2011-01-18 | Amag Pharmaceuticals, Inc. | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
JP5064612B2 (ja) | 1999-04-09 | 2012-10-31 | エーエムエージー ファーマシューティカルズ,インコーポレイテッド | 還元された炭水化物類及び炭水化物誘導体で被覆された熱的に安定なコロイド状酸化鉄 |
US6495177B1 (en) | 1999-08-13 | 2002-12-17 | Warner Chilcott Laboratories Ireland Limited | Orally dissolvable nutritional supplement |
AT500063A1 (de) | 1999-11-23 | 2005-10-15 | Sandoz Ag | Beschichtete tablettenkerne |
US20020119174A1 (en) | 2000-07-26 | 2002-08-29 | Gardlik John Michael | Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates |
AU2002220280A1 (en) | 2000-12-07 | 2002-06-18 | Ad "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj | Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
JP2002260951A (ja) | 2000-12-28 | 2002-09-13 | Denso Corp | 積層型誘電素子及びその製造方法,並びに電極用ペースト材料 |
US20030023208A1 (en) | 2001-07-24 | 2003-01-30 | Osypka Thomas P. | Apparatus for vascular access |
EP1492821B1 (en) | 2002-04-09 | 2006-08-02 | Pharmacosmos Holding A/S | Iron dextrin compounds for the treatment of iron deficiency anaemia |
WO2004000368A1 (en) | 2002-06-21 | 2003-12-31 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
DE10249552A1 (de) * | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
US6960571B2 (en) | 2003-03-14 | 2005-11-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
US20060116349A1 (en) | 2003-03-14 | 2006-06-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
JP2007509974A (ja) | 2003-10-31 | 2007-04-19 | アルザ・コーポレーシヨン | 3−アミノプロピル−n−ブチルホスフィン酸の増大した吸収のための組成物および薬用量形態 |
US20060134227A1 (en) | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
SI1848446T1 (sl) | 2005-02-09 | 2010-01-29 | Vifor Int Ag | Uporaba Ĺľelezove(III)-kompleksne spojine |
EP1757299A1 (de) | 2005-08-25 | 2007-02-28 | Vifor (International) Ag | Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung |
DK1973549T3 (en) | 2006-01-06 | 2016-11-21 | Vifor (International) Ag | Methods and compositions for administration of the iron |
US8778878B2 (en) | 2007-01-29 | 2014-07-15 | Chyna, LLC | Use of ferritin to treat iron disorders |
US8071542B2 (en) | 2007-01-29 | 2011-12-06 | Chyna, LLC | Use of ferritin to treat iron deficiency disorders |
EP2155850B1 (en) | 2007-05-18 | 2014-04-16 | Raffinerie Notre Dame - Orafti S.A. | Method for providing fragrance to a substrate; fragrance-containing substrate |
EP1997833A1 (de) | 2007-05-29 | 2008-12-03 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
FR2934272B1 (fr) | 2008-07-24 | 2013-08-16 | Roquette Freres | Procede de preparation de compositions a base de matiere amylacee et de polymere synthetique. |
HUE030866T2 (en) | 2009-03-25 | 2017-06-28 | Pharmacosmos Holding As | Stable iron-oligosaccharide compound |
FR2951177B1 (fr) | 2009-10-09 | 2012-12-21 | Roquette Freres | Procede de preparation de derives acetyles de matiere amylacee |
US20120214986A1 (en) | 2009-11-04 | 2012-08-23 | Symed Labs Limited | Process for the preparation of iron (iii) carboxymaltose complex |
US9120838B2 (en) | 2011-04-18 | 2015-09-01 | Curators Of The University Of Missouri | Saccharide conjugates |
EP2877848A4 (en) | 2012-07-27 | 2016-03-23 | Intrinsic Life Sciences Llc | METHOD FOR TREATING FERMENTED ANEMIA |
CA2889855A1 (en) | 2012-11-01 | 2014-05-08 | Robert S. Katz | Methods for treating fibromyalgia |
CN104918486B (zh) | 2012-11-30 | 2017-12-15 | 法玛科思莫斯股份公司 | 冷冻保护试剂,冷冻保护和冷冻保存的组合物,其用途,和冷冻保存方法 |
CN107438626A (zh) | 2015-03-23 | 2017-12-05 | 苏文生命科学有限公司 | 水溶性三价铁碳水化合物复合物的制备 |
WO2016181195A1 (en) | 2015-05-08 | 2016-11-17 | Suven Life Sciences Limited | Improved process for water soluble iron carbohydrate complexes |
EP3339329A1 (en) | 2016-12-22 | 2018-06-27 | LEK Pharmaceuticals d.d. | Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes |
-
2007
- 2007-01-08 DK DK07716309.5T patent/DK1973549T3/en active
- 2007-01-08 CA CA2635894A patent/CA2635894C/en not_active Expired - Fee Related
- 2007-01-08 KR KR1020147024469A patent/KR20140117678A/ko not_active Application Discontinuation
- 2007-01-08 EP EP07716309.5A patent/EP1973549B1/en not_active Revoked
- 2007-01-08 CA CA2953964A patent/CA2953964A1/en not_active Withdrawn
- 2007-01-08 AU AU2007205167A patent/AU2007205167B2/en active Active
- 2007-01-08 KR KR1020177005732A patent/KR101905340B1/ko active IP Right Grant
- 2007-01-08 PT PT77163095T patent/PT1973549T/pt unknown
- 2007-01-08 US US11/620,986 patent/US7754702B2/en active Active
- 2007-01-08 EP EP13166988.9A patent/EP2626074A1/en not_active Withdrawn
- 2007-01-08 WO PCT/US2007/000176 patent/WO2007081744A2/en active Application Filing
- 2007-01-08 KR KR1020187018660A patent/KR20180077337A/ko not_active Application Discontinuation
- 2007-01-08 EP EP16172826.6A patent/EP3081219A1/en active Pending
- 2007-01-08 CN CN2007800020060A patent/CN101365458B/zh not_active Ceased
- 2007-01-08 KR KR1020087016352A patent/KR20080082674A/ko not_active Application Discontinuation
-
2009
- 2009-03-31 HK HK09103049.6A patent/HK1125044A1/xx not_active IP Right Cessation
-
2010
- 2010-05-25 US US12/787,283 patent/US8431549B2/en active Active
-
2013
- 2013-03-19 US US13/847,254 patent/US20130230565A1/en not_active Abandoned
- 2013-12-09 US US14/100,717 patent/US8895612B2/en active Active
-
2015
- 2015-04-10 US US14/683,415 patent/US10478450B2/en active Active
-
2016
- 2016-10-19 CY CY20161101047T patent/CY1118780T1/el unknown
-
2018
- 2018-04-20 US US15/958,930 patent/US11433091B2/en active Active
- 2018-11-15 US US16/192,681 patent/US11406656B2/en active Active
-
2019
- 2019-06-11 US US16/438,340 patent/US11478502B2/en active Active
-
2020
- 2020-03-20 US US16/825,121 patent/US11344568B2/en active Active
- 2020-03-20 US US16/825,337 patent/US11364260B2/en active Active
-
2022
- 2022-06-16 US US17/842,483 patent/US20230008240A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118780T1 (el) | Μεθοδοι και συνθεσεις για χορηγηση σιδηρου | |
CY1125077T1 (el) | Αγωγη της ανεπαρκειας και ελλειψης βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3 | |
CY1120547T1 (el) | Νανοσωματιδιο που περιλαμβανει ραπαμυκινη και αλβουμινη ως αντικαρκινικος παραγοντας | |
CY1120022T1 (el) | Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας | |
CY1118103T1 (el) | Συνθεση χαμηλης δοσης τοπιραματης/φαιντερμινης και μεθοδοι χρησης αυτης | |
CY1111478T1 (el) | Ενδειξη δοσολογιας προγεστερονης στην αντιμετωπιση τραυματικης εγκεφαλικης βλαβης | |
CY1120536T1 (el) | Μεθοδος και συνθεσεις για τη θεραπευτικη αγωγη του καρκινου | |
CY1117476T1 (el) | Ανταγωνιστες συμπληρωματων και οι χρησεις αυτων | |
CY1106283T1 (el) | Κινολινυλ-πυρρολοπυραζολες | |
CY1115350T1 (el) | Χρησεις αναστολεων της dpp iv | |
CY1109786T1 (el) | Μεθοδοι για την θεραπευτικη αγωγη ρευματικων ασθενειων με την χρησιμοποιηση ενος διαλυτου μοριου ctla4 | |
CY1106774T1 (el) | Συνθεσεις φαρμακευτικων μεσων με βαση αλατα του τιοτροπιου και αλατα της σαλμετερολης | |
TW200700093A (en) | Pharmaceutical composition for the treatment of cancer | |
EA201791669A3 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
CY1116156T1 (el) | Παραγωγα πυριμιδινης συνδεδεμενα με οξυγονο | |
GB2442915B (en) | Perylenequinone derivatives and uses thereof | |
NO20072733L (no) | Doseformer | |
CY1107623T1 (el) | Μεθοδος αγωγης συμπτωματων ορμονικων μεταβολων, περιλαμβανομενων των εξαψεων | |
IL184951A0 (en) | Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer | |
CY1116494T1 (el) | Θεραπευτικη αγωγη θρομβοεμβολικων διαταραχων με ριβαροξαβανη | |
TW200730532A (en) | Camptothecin derivatives as chemoradiosensitizing agents | |
CY1107429T1 (el) | Υποκατεστημενες ν-κυκλοεξυλιμιδαζολινονες με τροποποιητικη δραση επι της mch | |
CY1112397T1 (el) | Συνδυασμενη θεραπεια για την αντιμετωπιση του καρκινου | |
EA200800397A1 (ru) | Композиции тизанидина и способы лечения с применением композиций | |
CY1113404T1 (el) | Μεθοδος αντιμετωπισης ή προληψης της πολυ- οργανικης ανεπαρκειας |